Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Glenzocimab

Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.

Product Specifications

CAS Number

2101829-58-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Research Grade MK-3655
MBS1563880-01 0.1 mg

Research Grade MK-3655

Sign In for Pricing
View Details
Research Grade MK-3655
MBS1563880-02 1 mg

Research Grade MK-3655

Sign In for Pricing
View Details
Research Grade MK-3655
MBS1563880-03 5x 1 mg

Research Grade MK-3655

Sign In for Pricing
View Details
CNGA4, NT (CNGA4, Cyclic nucleotide-gated cation channel alpha-4, Cyclic nucleotide-gated channel alpha-4) (PE) discontinued
034039-PE 200 µL

CNGA4, NT (CNGA4, Cyclic nucleotide-gated cation channel alpha-4, Cyclic nucleotide-gated channel alpha-4) (PE) discontinued

Sign In for Pricing
View Details
Phospho-VEGF Receptor 2 (Tyr1214) Rabbit pAb
E2310186 100 µL

Phospho-VEGF Receptor 2 (Tyr1214) Rabbit pAb

Sign In for Pricing
View Details
CCCP
T7081-01 100 mg

CCCP

Sign In for Pricing
View Details